Exact Mass: 840.3491

Albanin H

2-(2,4-dihydroxyphenyl)-8-{5-[(E)-2-[2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-8-yl]ethenyl]-3,5-dimethylcyclohex-2-en-1-yl}-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4H-chromen-4-one

Albanin H is found in fruits. Albanin H is a constituent of Morus alba (white mulberry). Constituent of Morus alba (white mulberry). Albanin H is found in fruits.

11-Hydroxyaclacinomycin X

Methyl 4-{[5-({5-[(3-amino-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid

Hexa-His

2-{2-[2-(2-{2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-(1H-imidazol-5-yl)propanamido}-3-(1H-imidazol-5-yl)propanamido)-3-(1H-imidazol-5-yl)propanamido]-3-(1H-imidazol-5-yl)propanamido}-3-(1H-imidazol-5-yl)propanoic acid

C36H44N18O7 (840.364)

PGP(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-[(10-methylundecanoyl)oxy]-2-{[(5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy]phosphoryl}oxy)propoxy]phosphonic acid

PGP(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of Lipoxin A5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

PGP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-2-[(10-methylundecanoyl)oxy]-3-{[(5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy]phosphoryl}oxy)propoxy]phosphonic acid

PGP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0), in particular, consists of one chain of one Lipoxin A5 at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

kaempferol 3-rhamninoside

(1S,2R)-2-{4-[(1R,3aS,4R,6aS)-4-(4-{[(1S,2R)-1,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol

sinapyl alcohol 9-O-feruloyl-4-O-alpha-rhamnopyranosyl-(1->2)-alpha-rhamnopyranosyl-(1->2)-beta-glucopyranoside|solargin III

C39H52O20 (840.3052)

C38H52N2O19

C38H52N2O19 (840.3164)

31,32-dihydroxy-82-(1-beta-D-glucopyranosyl)-oxy-1,4,5,10,15,20,22,24-(21H,23H)-octahydro-132-(methoxycarbonyl)-4,5-dioxo-4,5-seco-phytoprophyrinate

C41H52N4O15 (840.3429)

C41H60O18

11-hydroxyaclacinomycin X

methyl 4-[5-[5-[(3-amino-6-methyl-5-oxo-2H-pyran-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl]oxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate

methyl 4-[5-[5-[(3-amino-6-methyl-5-oxo-2H-pyran-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl]oxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate

(15R)-hydroxyvinamidine|hydroxyvinamidine

C46H56N4O11 (840.3945)

Mureidomycin A

5-methoxyhedyotisol A

5alpha-4,5-dihydro-16beta-O-acetyl-scillirosidin-3-O-alpha-L-thevetosido-(1-4)-beta-D-glucoside

euphodendroidin Q

C45H48N2O14 (840.3105)

Albanin H

Formoterol fumarate

formoterol fumarate dihydrate

C42H56N4O14 (840.3793)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

N,N-di(2-ethylhexyl)-1,7-di(thiophen-2-yl)perylene-3,4,9,10-tetracarboxylic acid bisimide

C48H52N6O4S2 (840.3491)

kaempferol 3-rhamninoside

kaempferol 3-rhamninoside

(3R)-3-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-18-amino-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide

(3R)-3-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-18-amino-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide

C35H52N8O16 (840.3501)

PGP(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

PGP(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0)

2-[4-[1,3-Dihydroxy-2-[4-[3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]propyl]-2,6-dimethoxyphenoxy]-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol

2-[4-[1,3-Dihydroxy-2-[4-[3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]propyl]-2,6-dimethoxyphenoxy]-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol

(C19H20N2)2. C10H8O6S2 (840.3015)

Ferroheme o

C49H60FeN4O5 (840.3913)

A ferroheme having a methyl group at ring position 8 and an isoprenoid chain at position 2.

Mebhydrolin napadisilate

Mebhydrolin napadisylate is a specific histamine H1 receptor antagonist.

methyl (1r,2r,4s)-4-({5-[(5-{[(2r,6s)-3-amino-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2r,4s)-4-({5-[(5-{[(2r,6s)-3-amino-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}oxy)-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (2r,4s)-4-{[5-({5-[(3-amino-6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (2r,4s)-4-{[5-({5-[(3-amino-6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

(1s,3s,6s,7e,10e,13r,16r,17s,18s,21r,22s,23e)-17-{[(2r,4r,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

(1s,3s,6s,7e,10e,13r,16r,17s,18s,21r,22s,23e)-17-{[(2r,4r,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

2-({[(1s)-1-{[(1r)-2-[(2s)-2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(3-hydroxyphenyl)propanoic acid

2-({[(1s)-1-{[(1r)-2-[(2s)-2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(3-hydroxyphenyl)propanoic acid

(2e)-3-(4-{[(2s,4s,5s)-3-[(4,5-dihydroxy-6-methyl-3-{[(3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2e)-3-(4-{[(2s,4s,5s)-3-[(4,5-dihydroxy-6-methyl-3-{[(3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C39H52O20 (840.3052)

(4s,7s,13r,22r)-2,5,8,11,14,20-hexahydroxy-22-(hydroxymethyl)-4-(1h-indol-3-ylmethyl)-7-[(4-methoxy-1h-indol-3-yl)methyl]-13,18-dimethyl-16-methylidene-24-thia-3,6,9,12,15,18,21,26-octaazabicyclo[21.2.1]hexacosa-1(25),2,5,8,11,14,20,23(26)-octaen-17-one

(4s,7s,13r,22r)-2,5,8,11,14,20-hexahydroxy-22-(hydroxymethyl)-4-(1h-indol-3-ylmethyl)-7-[(4-methoxy-1h-indol-3-yl)methyl]-13,18-dimethyl-16-methylidene-24-thia-3,6,9,12,15,18,21,26-octaazabicyclo[21.2.1]hexacosa-1(25),2,5,8,11,14,20,23(26)-octaen-17-one

C40H44N10O9S (840.3013)

5-(acetyloxy)-3a,3b-dihydroxy-7-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-2-yl acetate

5-(acetyloxy)-3a,3b-dihydroxy-7-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-2-yl acetate

(2e)-3-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2e)-3-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C39H52O20 (840.3052)

17-{[5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

17-{[5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

8-[(8s,8ar,12as)-2-(2,4-dihydroxyphenyl)-5-hydroxy-9,9,11-trimethyl-3-(3-methylbut-2-en-1-yl)-4-oxo-8h,8ah,10h,12ah-chromeno[7,8-c]isochromen-8-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

8-[(8s,8ar,12as)-2-(2,4-dihydroxyphenyl)-5-hydroxy-9,9,11-trimethyl-3-(3-methylbut-2-en-1-yl)-4-oxo-8h,8ah,10h,12ah-chromeno[7,8-c]isochromen-8-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

rudolfomycin

6-({5-[(2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl)oxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl}oxy)-5-ethenyl-4-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-5,6-dihydro-4h-pyran-3-carboxylic acid

6-({5-[(2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl)oxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl}oxy)-5-ethenyl-4-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-5,6-dihydro-4h-pyran-3-carboxylic acid

C38H52N2O19 (840.3164)

9-hydroxy-9-{[9-hydroxy-9-({[2-(hydroxymethyl)-3-(5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl)prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carbonyloxy]methyl}-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

9-hydroxy-9-{[9-hydroxy-9-({[2-(hydroxymethyl)-3-(5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl)prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carbonyloxy]methyl}-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

C45H60O15 (840.3932)

(4s,5r,6s)-6-{[(2s,3r,4r,5s,6r)-5-{[(2r,3r,4s,5r,6r)-2-{[(2s,3s,4r,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-ethenyl-4-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-5,6-dihydro-4h-pyran-3-carboxylic acid

(4s,5r,6s)-6-{[(2s,3r,4r,5s,6r)-5-{[(2r,3r,4s,5r,6r)-2-{[(2s,3s,4r,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-ethenyl-4-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-5,6-dihydro-4h-pyran-3-carboxylic acid

C38H52N2O19 (840.3164)

(2s)-2-({[(1s)-1-{[(1s,2s)-2-[(2s)-2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-({[(1s)-1-{[(1s,2s)-2-[(2s)-2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid

2-({[1-({2-[2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl}-c-hydroxycarbonimidoyl)-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(3-hydroxyphenyl)propanoic acid

2-({[1-({2-[2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl}-c-hydroxycarbonimidoyl)-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(3-hydroxyphenyl)propanoic acid

(1r,2s,3ar,3bs,5r,5as,7s,9as,9br,11ar)-5-(acetyloxy)-3a,3b-dihydroxy-7-{[(2r,3s,4s,5s,6s)-3-hydroxy-4-methoxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-2-yl acetate

(1r,2s,3ar,3bs,5r,5as,7s,9as,9br,11ar)-5-(acetyloxy)-3a,3b-dihydroxy-7-{[(2r,3s,4s,5s,6s)-3-hydroxy-4-methoxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-2-yl acetate

8-[(8s,8ar,12ar)-2-(2,4-dihydroxyphenyl)-5-hydroxy-9,9,11-trimethyl-3-(3-methylbut-2-en-1-yl)-4-oxo-8h,8ah,10h,12ah-chromeno[7,8-c]isochromen-8-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

8-[(8s,8ar,12ar)-2-(2,4-dihydroxyphenyl)-5-hydroxy-9,9,11-trimethyl-3-(3-methylbut-2-en-1-yl)-4-oxo-8h,8ah,10h,12ah-chromeno[7,8-c]isochromen-8-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-5-{[(2s,4s,5s,6s)-5-{[(2s,6s)-3-amino-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-5-{[(2s,4s,5s,6s)-5-{[(2s,6s)-3-amino-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

2-(2,4-dihydroxyphenyl)-8-[2-(2,4-dihydroxyphenyl)-5-hydroxy-9,9,11-trimethyl-3-(3-methylbut-2-en-1-yl)-4-oxo-8h,8ah,10h,12ah-chromeno[7,8-c]isochromen-8-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

2-(2,4-dihydroxyphenyl)-8-[2-(2,4-dihydroxyphenyl)-5-hydroxy-9,9,11-trimethyl-3-(3-methylbut-2-en-1-yl)-4-oxo-8h,8ah,10h,12ah-chromeno[7,8-c]isochromen-8-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

5-{[(4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy]methyl}-10-[(2r,4s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]-2-(2,3-dihydroxybutan-2-yl)-11-hydroxy-1-oxatetraphene-4,7,12-trione

5-{[(4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy]methyl}-10-[(2r,4s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]-2-(2,3-dihydroxybutan-2-yl)-11-hydroxy-1-oxatetraphene-4,7,12-trione

C43H56N2O15 (840.3681)

(1s,3s,6s,7e,10e,13r,16s,17r,18r,21r,22r)-17-{[(2r,4s,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-27-hydroxy-6,18-dimethyl-23,25-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,24(27)-pentaene-4-carboxylic acid

(1s,3s,6s,7e,10e,13r,16s,17r,18r,21r,22r)-17-{[(2r,4s,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-27-hydroxy-6,18-dimethyl-23,25-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,24(27)-pentaene-4-carboxylic acid

5-{[(4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy]methyl}-10-{5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}-2-(2,3-dihydroxybutan-2-yl)-11-hydroxy-1-oxatetraphene-4,7,12-trione

5-{[(4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy]methyl}-10-{5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-(dimethylamino)-6-methyloxan-2-yl}-2-(2,3-dihydroxybutan-2-yl)-11-hydroxy-1-oxatetraphene-4,7,12-trione

C43H56N2O15 (840.3681)

(1s,3s,6s,7e,10e,13r,16s,17s,18s,21r,22r)-17-{[(2r,4r,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

(1s,3s,6s,7e,10e,13r,16s,17s,18s,21r,22r)-17-{[(2r,4r,5s,6r)-5-(3,5-dichloro-1h-pyrrole-2-amido)-4-hydroxy-6-methyloxan-2-yl]oxy}-3,22-diethyl-23-hydroxy-6,18-dimethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-4,7,10,14,23-pentaene-4-carboxylic acid

2-{4-[(1r,3as,4r,6as)-4-(4-{[1,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol

2-{4-[(1r,3as,4r,6as)-4-(4-{[1,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol

2-{[(1-{[(1r,2r)-2-[2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[(2z,4s,5s)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl)-c-hydroxycarbonimidoyl]amino}-3-(3-hydroxyphenyl)propanoic acid

2-{[(1-{[(1r,2r)-2-[2-amino-3-(3-hydroxyphenyl)-n-methylpropanamido]-1-({[(2z,4s,5s)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl)-c-hydroxycarbonimidoyl]amino}-3-(3-hydroxyphenyl)propanoic acid